Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageDebt RatioDebt to EquityEnterprise ValueEquity AverageEquity RatioInventory AverageInvested Capital

Mainz Biomed (MYNZ) Assets Average (2021 - 2025)

Mainz Biomed's Assets Average history spans 4 years, with the latest figure at $14.3 million for Q4 2024.

  • For Q4 2024, Assets Average fell 19.64% year-over-year to $14.3 million; the TTM value through Dec 2024 reached $14.3 million, down 19.64%, while the annual FY2024 figure was $14.3 million, 19.64% down from the prior year.
  • Assets Average for Q4 2024 was $14.3 million at Mainz Biomed, down from $17.8 million in the prior quarter.
  • Across five years, Assets Average topped out at $17.8 million in Q4 2023 and bottomed at $5.4 million in Q4 2021.
  • The 4-year median for Assets Average is $14.7 million (2022), against an average of $13.2 million.
  • The largest annual shift saw Assets Average surged 182.64% in 2022 before it decreased 19.64% in 2024.
  • A 4-year view of Assets Average shows it stood at $5.4 million in 2021, then skyrocketed by 182.64% to $15.1 million in 2022, then rose by 17.73% to $17.8 million in 2023, then dropped by 19.64% to $14.3 million in 2024.
  • Per Business Quant, the three most recent readings for MYNZ's Assets Average are $14.3 million (Q4 2024), $17.8 million (Q4 2023), and $15.1 million (Q4 2022).